These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 18561466

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J, Troy DE, Alexander E.
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN.
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract] [Full Text] [Related]

  • 10. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov 20; 63(224):64556-88. PubMed ID: 10339052
    [Abstract] [Full Text] [Related]

  • 11. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM.
    Food Drug Law J; 2000 Nov 20; 55(4):477-89. PubMed ID: 12025847
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS, Shapiro JK.
    Food Drug Law J; 2003 Nov 20; 58(3):353-64. PubMed ID: 14626983
    [No Abstract] [Full Text] [Related]

  • 14. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL.
    Spec Law Dig Health Care Law; 1997 Sep 20; (223):9-45. PubMed ID: 10173273
    [No Abstract] [Full Text] [Related]

  • 15. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH, Stanley E, Hudson K.
    Oklahoma Law Rev; 2004 Sep 20; 57(2):251-302. PubMed ID: 15658034
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2010 Jan 04; ():1-31. PubMed ID: 20217914
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmaceuticals and medical devices: FDA oversight.
    Berry MD.
    Issue Brief Health Policy Track Serv; 2013 Dec 30; ():1-123. PubMed ID: 24482893
    [No Abstract] [Full Text] [Related]

  • 20. The impact of FDA reform.
    Trunzo J.
    Med Device Technol; 2003 Apr 30; 14(3):36-7. PubMed ID: 12789699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.